Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interaction Empowerment in Mobile Health: Concepts, Challenges, and Perspectives.
Hamberger M, Ikonomi N, Schwab JD, Werle SD, Fürstberger A, Kestler AM, Holderried M, Kaisers UX, Steger F, Kestler HA. Hamberger M, et al. Among authors: kestler am. JMIR Mhealth Uhealth. 2022 Apr 13;10(4):e32696. doi: 10.2196/32696. JMIR Mhealth Uhealth. 2022. PMID: 35416786 Free PMC article.
Digitalization of adverse event management in oncology to improve treatment outcome-A prospective study protocol.
Kestler AMR, Kühlwein SD, Kraus JM, Schwab JD, Szekely R, Thiam P, Hühne R, Jahn N, Fürstberger A, Ikonomi N, Balig J, Schuler R, Kuhn P, Steger F, Seufferlein T, Kestler HA. Kestler AMR, et al. PLoS One. 2021 Jun 4;16(6):e0252493. doi: 10.1371/journal.pone.0252493. eCollection 2021. PLoS One. 2021. PMID: 34086740 Free PMC article. Clinical Trial.
AMBAR - Interactive Alteration annotations for molecular tumor boards.
Fürstberger A, Ikonomi N, Kestler AMR, Marienfeld R, Schwab JD, Kuhn P, Seufferlein T, Kestler HA. Fürstberger A, et al. Among authors: kestler amr. Comput Methods Programs Biomed. 2023 Oct;240:107697. doi: 10.1016/j.cmpb.2023.107697. Epub 2023 Jul 6. Comput Methods Programs Biomed. 2023. PMID: 37441893 Free article.
Leitlinienreport der S3-Leitlinie zum exokrinen Pankreaskarzinom.
Seufferlein T, Mayerle J, Blödt S, Derenz S, Follmann M, Kestler A, Köster MJ, Langer T, Rütters D, Wesselmann S, Lorenz P. Seufferlein T, et al. Z Gastroenterol. 2022 Jun;60(6):288-391. doi: 10.1055/a-1771-6893. Epub 2022 Jun 14. Z Gastroenterol. 2022. PMID: 35700969 Free article. German. No abstract available.
S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL.
Seufferlein T, Mayerle J, Böck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. Seufferlein T, et al. Z Gastroenterol. 2022 Jun;60(6):991-1037. doi: 10.1055/a-1771-6811. Epub 2022 Jun 7. Z Gastroenterol. 2022. PMID: 35671996 Free article. German. No abstract available.
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.
Seufferlein T, Uhl W, Kornmann M, Algül H, Friess H, König A, Ghadimi M, Gallmeier E, Bartsch DK, Lutz MP, Metzger R, Wille K, Gerdes B, Schimanski CC, Graupe F, Kunzmann V, Klein I, Geissler M, Staib L, Waldschmidt D, Bruns C, Wittel U, Fichtner-Feigl S, Daum S, Hinke A, Blome L, Tannapfel A, Kleger A, Berger AW, Kestler AMR, Schuhbaur JS, Perkhofer L, Tempero M, Reinacher-Schick AC, Ettrich TJ. Seufferlein T, et al. Among authors: kestler amr. Ann Oncol. 2023 Jan;34(1):91-100. doi: 10.1016/j.annonc.2022.09.161. Epub 2022 Oct 7. Ann Oncol. 2023. PMID: 36209981 Free article. Clinical Trial.
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response.
Beutel AK, Schütte L, Scheible J, Roger E, Müller M, Perkhofer L, Kestler AMTU, Kraus JM, Kestler HA, Barth TFE, Lemke J, Kornmann M, Ettrich TJ, Gout J, Seufferlein T, Kleger A. Beutel AK, et al. Among authors: kestler amtu. Cancers (Basel). 2021 May 21;13(11):2539. doi: 10.3390/cancers13112539. Cancers (Basel). 2021. PMID: 34064221 Free PMC article.
13 results